chartexchange

CGTX
Cognition Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 1:56:44 PM EST
0.61USD+1.650%(+0.01)232,484
Pre-marketNov 19, 2026 9:05:30 AM EST
0.61USD+1.667%(+0.01)
0.5200Bid0.7100Ask0.1900Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Purchase, NY, USA
Previous Close
$0.60
Beta
2.54
52-Week High
$1.81 2025-12-03
52-Week Low
$0.55 2026-03-30
SMA 50
$0.82
SMA 200
$1.02
Avg. Vol 10D
387,645
Avg. Vol 30D
543,393
Avg. Vol 90D
497,316
Relative Vol
0.41
87.39M
0.5700%
2,700,000
1,500
CGTX Profile

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.

CGTX Performance
PeriodPriceDateChangeBeta
1W0.682026-11-12-9.86%2.224
1M0.732026-10-19-16.20%1.549
3M0.982026-08-19-37.72%1.408
6M1.112026-05-19-45.08%1.220
1Y1.392025-11-19-56.14%2.538
2Y0.442024-11-19+37.30%—
5Y10.312021-11-19-94.09%1.377
CGTX Stock Summary

Cognition Therapeutics, Inc. Common Stock (NASDAQ:CGTX) stock price today is $0.61, and today's volume is 222,336. CGTX is up 1.600% today. The 30 day average volume is 543,393. CGTX market cap is $57.97M with 95.10M shares outstanding.